Elbit announced Dec. 7 that its board of directors in Haifa hasinstructed management to explore the possibility of spinning offits healthcare, defense and commercial business interests intoseparately run companies. Under the proposal, Elscint and the
Elbit announced Dec. 7 that its board of directors in Haifa hasinstructed management to explore the possibility of spinning offits healthcare, defense and commercial business interests intoseparately run companies.
Under the proposal, Elscint and the ultrasound assets of Diasonicsin Santa Clara, CA, Vingmed Sound A/S of Norway and Sonotron HoldingAG of Switzerland would be merged into a single company. In combination,these businesses are expected to produce more than $500 millionin sales in 1995.
In a separate development, Elbit took a step toward consolidatingits ultrasound operations in November by purchasing the ultrasound-relatedassets of Elscintec, a manufacturing and R&D group owned byElscint, a subsidiary of Elbit. The deal is worth at least $14million, according to Elbit.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.